KCAS Bio is engaging with the scientific community in Europe throughout the fall of 2025. From attending sessions to exhibiting at booths, our experts are ready to share knowledge, showcase our capabilities, and discuss how we can support your research across discovery and clinical development.

EUROTOX 2025 Congress
Date: September 14–17, 2025
Location: Athens, Greece
EUROTOX 2025 will gather experts and emerging scientists to explore sustainable health and innovations in toxicology. KCAS Bio supports toxicology advancements with GLP studies that generate high-quality bioanalytical and biomarker data for preclinical drug development, along with immunogenicity testing, dose formulation analysis, and advanced cellular assays.

Festival of Biologics 2025
Date: September 30–October 2, 2025
Location: Basel, Switzerland
This global gathering connects pharma, biotech, academia, regulators, and investors to discuss biologic therapies, including antibodies, cell and gene therapies (CGT), immunotherapies, and biosimilars. KCAS Bio supports programs across mAbs, bi- and trispecifics, ADCs, vaccines and CGT, providing integrated bioanalytical, biomarker, and cell-based assay services to accelerate complex biologics from discovery through clinical development.

Nordic Life Science Days 2025
Date: October 13–14, 2025
Location: Gothenburg, Sweden
NLSDays 2025 brings together scientists and business leaders to explore innovation, early-stage drug development, and partnerships across Europe. KCAS Bio will be exhibiting at the French Pavilion, showcasing our expertise in biologics, cell and gene therapies, and immunogenicity assessment, delivering high-quality, regulatory-aligned data to advance complex therapeutic programs.

EBF Open Symposium 2025
Date: November 18–20, 2025
Location: Barcelona, Spain
The 18th EBF Open Symposium will focus on “Tuning in to Tomorrow,” highlighting emerging technologies, regulatory challenges, and innovations in bioanalysis. KCAS Bio will be exhibiting, conducting workshops, and delivering talks, providing advanced bioanalytical services across clinical development to help partners generate reliable, regulatory-compliant data and move therapies forward efficiently.

Our team is eager to connect with peers, share our expertise, and explore new opportunities to advance drug development together.